Dr. Mohammed Mazharuddin is a board-certified psychiatrist and the Founder of Ascend Psychiatry, integrating evidence-based treatment, interventional psychiatry, and holistic care.
He completed his residency training at Creedmoor Psychiatric Center and New York- Presbyterian/Columbia University Irving Medical Center, where he developed a passion and expertise in treating complex mood and psychotic disorders, treatment-resistant depression, and acute psychiatric care.
Dr. Mazharuddin previously served as Medical Director of NY Ketamine Infusions, where he oversaw clinical operations and gained extensive experience in the use of novel and interventional treatments for treatment-resistant mood disorders. In this role, he developed specialized expertise in ketamine-based therapies and the integration of emerging biological treatments into outpatient psychiatric practice.